BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7688135)

  • 1. [Cytokines and hepatitis].
    Degos F
    Rev Prat; 1993 Mar; 43(5):569-73. PubMed ID: 7688135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinfection by hepatitis B virus and hepatitis C virus.
    Pontisso P; Gerotto M; Benvegnù L; Chemello L; Alberti A
    Antivir Ther; 1998; 3(Suppl 3):137-42. PubMed ID: 10726063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon therapy in chronic active viral hepatitis].
    Lengyel G; Fehér J
    Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection: an overview.
    Hwang SJ
    J Microbiol Immunol Infect; 2001 Dec; 34(4):227-34. PubMed ID: 11825001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C--clinical profile.
    Bhandari B; Pal A
    J Indian Med Assoc; 2007 Aug; 105(8):453-4, 456, 465. PubMed ID: 18236909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon therapy of chronic viral hepatitis in Hungary: 5-year experience. A multicenter study].
    Pár A; Telegdy L; Gógl A; Müller E
    Orv Hetil; 1999 May; 140(22):1227-33. PubMed ID: 10377733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B and C viruses: molecular identification and targeted antiviral therapies.
    Berenguer M; Wright TL
    Proc Assoc Am Physicians; 1998; 110(2):98-112. PubMed ID: 9542765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hepatitis B and hepatitis C virus replication on the actions of interferon.
    Foster GR; Thomas HC
    Antiviral Res; 1994 Jul; 24(2-3):131-6. PubMed ID: 7526787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drugs active against hepatitis viruses].
    Goudeau A
    Rev Prat; 1997 Mar; 47(6):640-5. PubMed ID: 9183938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response.
    Donadel E; Pontisso P; Ruvoletto MG; Gerotto M; De Salvo G; Chemello L; Casarin C; Alberti A
    J Med Virol; 1998 Jan; 54(1):7-11. PubMed ID: 9443103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hepatitis B].
    Telegdy L
    Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon and other therapies for hepatitis B and hepatitis C infections.
    Rothstein KD; Munoz SJ
    Clin Lab Med; 1996 Jun; 16(2):465-91. PubMed ID: 8792083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines in the pathogenesis and treatment of infectious diseases.
    Lau AS
    Adv Pediatr Infect Dis; 1994; 9():211-36. PubMed ID: 7510110
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B.
    Zhang X; Zoulim F; Habersetzer F; Xiong S; Trépo C
    J Med Virol; 1996 Jan; 48(1):8-16. PubMed ID: 8825704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of interferon in hepatitis B and C.
    Schalm SW
    Verh K Acad Geneeskd Belg; 2009; 71(1-2):87-99. PubMed ID: 19739400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.